Aminoglycoside nephrotoxicity.
D000617:Aminoglycosides / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport; D002118:Calcium / Q000494:pharmacology; D004351:Drug Resistance; D005260:Female; D005839:Gentamicins / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007672:Kidney Cortex / Q000378:metabolism; D007674:Kidney Diseases / Q000139:chemically induced*; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism; D008297:Male; D008954:Models, Biological; D010743:Phospholipids / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D000617:Aminoglycosides; D005839:Gentamicins; D010743:Phospholipids; D000254:Sodium-Potassium-Exchanging ATPase; D002118:Calcium